Behçet's syndrome.
Stanford
M R
MR
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D011379:Prognosis; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use; D014786:Vision Disorders / Q000188:drug therapy* / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D014409:Tumor Necrosis Factor-alpha